Home › NDC Lookup › RxCUI directory › RxCUI 2697139

1 ML marstacimab-hncq 150 MG/ML Auto-Injector — RxCUI 2697139

Name: 1 ML marstacimab-hncq 150 MG/ML Auto-Injector (RxCUI 2697139)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2697139 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2697139

Official name1 ML marstacimab-hncq 150 MG/ML Auto-Injector

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asmarstacimab-hncq 150 MG per 1 ML Auto-Injector; marstacimab-hncq 150 MG in 1 ML Auto-Injector

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)77 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1 ML marstacimab-hncq 150 MG/ML Auto-Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML marstacimab-hncq 150 MG/ML Auto-Injector RxCUI 2697139 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Marstacimab 2697133 IN
- Marstacimab-hncq 2697132 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Hympavzi 2697141 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Marstacimab Auto-Injector 2697136 SCDF
- Marstacimab-hncq Auto-Injector 2697138 SCDFP
- Marstacimab Injectable Product 2697135 SCDG
- Marstacimab-hncq Injectable Product 2697137 SCDGP
- Marstacimab Auto-Injector [Hympavzi] 2697144 SBDF
- Marstacimab-hncq Auto-Injector [Hympavzi] 2697145 SBDFP
- Hympavzi Injectable Product 2697143 SBDG
- Auto-Injector 1649570 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Marstacimab-hncq 150 MG/ML 2697134 SCDC
- 1 ML marstacimab-hncq 150 MG/ML Auto-Injector [Hympavzi] 2697146 SBD
- Marstacimab-hncq 150 MG/ML [Hympavzi] 2697142 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Marstacimab-hncq 150 MG/ML SCDC · 2697134
Marstacimab Auto-Injector SCDF · 2697136
Marstacimab-hncq Auto-Injector SCDFP · 2697138
Marstacimab Injectable Product SCDG · 2697135
Marstacimab-hncq Injectable Product SCDGP · 2697137

Brand-Name Concepts

1 ML marstacimab-hncq 150 MG/ML Auto-Injector [Hympavzi] SBD · 2697146
Marstacimab-hncq 150 MG/ML [Hympavzi] SBDC · 2697142
Marstacimab Auto-Injector [Hympavzi] SBDF · 2697144
Marstacimab-hncq Auto-Injector [Hympavzi] SBDFP · 2697145
Hympavzi Injectable Product SBDG · 2697143
Hympavzi BN · 2697141

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2697139 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00069-0775-01	1 SYRINGE in 1 CARTON (0069-0775-01) / .5 mL in 1 SYRINGE	HYMPAVZI	Pfizer Laboratories Div Pfizer Inc	2026-06-22
00069-1510-01	1 SYRINGE in 1 CARTON (0069-1510-01) / 1 mL in 1 SYRINGE	HYMPAVZI	Pfizer Laboratories Div Pfizer Inc	2025-10-15
00069-2151-01	1 SYRINGE in 1 CARTON (0069-2151-01) / 1 mL in 1 SYRINGE	HYMPAVZI	Pfizer Laboratories Div Pfizer Inc	2024-11-05

Observed labelers: Pfizer Laboratories Div Pfizer Inc (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J7172	Inj marstacim-hncq, 0.5 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.